If you've been following along, I try and go out of my way to discuss risk management techniques, tools and signals when the market gives them to us. Whenever I lay out a thesis, I like to talk about what the market should look like in the case that we are correct, while at the same time outlining what the environment would look like if we are wrong. The idea is to picture both scenarios and as the data comes in, try to identify which outcome we're in as quickly as possible.

Biotechnology has not been something you've been hearing me pound the table about for a long time. I was a huge Biotech bull in 2015, but this has not been something we've wanted to be involved with much since. The biggest reason is for the dramatic under-performance. The winning areas have been in Technology, Industrials and Financials, not Biotechnology. If we've wanted to be in healthcare at all it's been in the Medical Device and Equipment stocks, not Pharma or Biotech.

It's 2018 now and things are changing; sectors are rotating. We're seeing strength in Energy, Materials and really just Natural Resources in general. Canada and Australia breaking out finally points to strength in that area as well.

Today we're going to talk specifically about Biotechnology and if/where we want to be involved. 

One of the things that often gets underrated is the power of simplicity. What's wrong with only looking at price and focusing in only on what matters most? I get that you love your moving averages and candlesticks and all sorts of momentum indicators. But the most important indicator is still price. So that's what we're going to look at today using OHLC Bar Charts.

Every month I host a conference call for All Star Charts Premium Members where we discuss ongoing themes throughout the global marketplace as well as changes in trends where new positions would be most appropriate. This includes U.S. Stocks & Sectors, International Stock Indexes, Commodities, Currencies and Interest Rate Markets.

We've been extremely bullish towards US and Global Stocks as they remain in strong uptrends on any sort of intermediate-term time horizon. I still think this is an environment where we need to be buying weakness in stocks, not selling strength. The weight of the evidence is still pointing to an increased amount of risk appetite, not risk aversion. We will go over a multi-timeframe approach on this conference call where we will start with the longer-term and then work our way down to more short-term to intermediate-term investing ideas. This will also include other assets like the US Dollar, Euro, Gold, Silver, Crude Oil and Interest Rates.

Natural Gas stocks? When was the last time you heard me talk about those?? There is a time and a place for everything. We've discussed the relative strength in Energy stocks as a group lately and have pointed out some interesting opportunities, particularly in the Oil Refinery space, Valero especially. That has worked very well in our favor the past few months.

But moving forward I think there are some extremely favorable risk vs reward scenarios within the Natural Gas stocks as well as all of them as a group.

We want to go into 2018 forgetting everything we thought we once knew. The process of approaching every market with an open mind is something that I think is very important. Our goals of profitability need to outweigh any emotions driven by ego.

I've been very critical of Gold, Silver and Precious Metals stocks since the Summer of 2016 when they hit the upside objectives we gave them earlier that year. Since then, it's been a sideways mess, with fast moves lower and abrupt mean reversions higher. These are characteristics of messy markets, not trending ones like U.S. Stocks were for example since, coincidentally (I doubt it) that Summer of 2016.

Today we're going to go over the best risk vs reward propositions in the Gold market as we enter 2018:

We do not make end of 2018 forecasts. I think it's irresponsible to think that we have any idea of what will happen a year from now. We want to reevaluate our thesis as time goes on and new data comes in. This reevaluation process occurs consistently throughout the entire year. How else can we manage risk responsibly? Are we supposed to place our bets after New Years and just hope for the best? Come on.

Take a deep breath. Forget everything we did this year and only think about where we are today. The idea is to keep an open mind and keep every option available. If we've loved something in 2017, that doesn't mean we can't hate it in 2018. Just because we've been shorting something this year, doesn't mean we can't be buyers in the next coming quarters. We're not here to be right, we're here to make money. We can't forget that and let ego take priority over profitability. It's important to be aware of our cognitive behavior patterns and this is one of them.

I have a workbook of charts where I keep the entire list of stocks in the Consumer Staples Sector. With the Equally-weighted Consumer Staples Index breaking out of a multi-year base, we want to find the stocks that are going to lead this sector higher.

Here is a list of the ones that stand out which are showing strength and a risk vs reward skewed in favor of the bulls following the longer-term and shorter-term uptrend in Consumer Staples:

Every month I host a conference call for All Star Charts Premium Members where we discuss ongoing themes throughout the global marketplace as well as changes in trends where new positions would be most appropriate. This includes U.S. Stocks & Sectors, International Stock Indexes, Commodities, Currencies and Interest Rate Markets.

We've been bullish towards US and Global Stocks as they remain in strong uptrends on any sort of intermediate-term time horizon. I still think this is an environment where we need to be buying weakness in stocks, not selling strength. The weight of the evidence is still pointing to an increased amount of risk appetite, not risk aversion. We will go over a multi-timeframe approach on this conference call where we will start with the longer-term and then work our way down to more short-term to intermediate-term investing ideas. This will also include other assets like the US Dollar, Euro, Gold, Silver, Crude Oil and Interest Rates.

There is a lot to be said for taking the time to analyze all of the stocks in an index. I find that process to be much more rewarding than obsessing over every 50 basis point move in the index itself. I've written in the past about how I think the Dow Jones Industrial Average is underrated. You can go through all 500 stocks in the S&P500 or just 30 of them in the DJIA and you'll get a quick snapshot of the health of the market. If there are more good ones than bad ones, it's probably not a downtrend in the index. If there are more bad stocks than good ones, it's likely the index will follow them lower as well.